Excellent air permeability fiberglass cast

The Excellent air permeability fiberglass cast is a water-activated orthopedic immobilization product composed of fiberglass reinforcement and a polyurethane resin matrix. It is supplied in standard dimensions of 10 cm by 360 cm, with each unit weighing 0.204 kg. The cast solidifies in 3 to 5 minutes and achieves sufficient structural strength within 20 minutes, making it suitable for external fracture fixation in non-weight-bearing and weight-bearing regions of the body.

The material system provides excellent X-ray radiolucency, allowing clear imaging without removal, and maintains air permeability to reduce skin maceration. It is water-resistant once cured and designed for single-use application, with packaging that requires dry storage to prevent premature curing. The fiberglass weave offers high tensile strength relative to its weight, and the polyurethane binder ensures consistent mouldability without excessive heat generation during setting.

This product is commonly used in trauma centers, outpatient clinics, and mobile medical units across Asia and Eastern Europe. Buyers typically order in bulk for hospital supply chains or distributor networks. Packaging is standardized at 10 bags per box and 9 boxes per carton. The shelf life is two years when stored at room temperature, and removal requires an electric cast saw. No adhesive or additional tools are needed for application beyond gloves and water.

Shaanxi Ansen Medical Technology Development Co., Ltd. is a supplier based in Xi'an, Shaanxi Province, China, specializing in orthopedic immobilization products. The company is registered as an imported supplier with harbor-tier trust verification, indicating verified export compliance and logistics capability. The listing does not disclose company history, employee count, or clinical certifications, and no third-party quality audits are referenced.

The supplier operates with a focus on manufacturing and exporting medical casts, with production aligned to standard medical device handling protocols. There is no public information on ISO certification, clinical testing data, or direct partnerships with hospitals. The response rate and average response time are not tracked, suggesting limited buyer communication infrastructure. The product line appears limited to this single cast model, with no indication of broader product development or R&D activity.